Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 163 M158 M156 M172 M159 M165 M 652 M Research & development —————— — Operating income 324 M348 M358 M221 M399 M357 M 1.33 B Non-Operating Income, Total 000000 0 Interest expense, net of interest capitalized 229 M224 M214 M203 M197 M199 M 813 M Non-Operating Income, excl. Interest Expenses -229 M-224 M-214 M-203 M-197 M-199 M -813 M Unusual income/expense —————— — Pretax income 197 M174 M196 M48 M243 M197 M 684 M Equity in earnings ———0—— — Taxes 55 M35 M8 M-4 M62 M51 M 117 M Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 142 M139 M188 M52 M181 M146 M 567 M Discontinued operations -4 M001 M00 1 M Net income 138 M139 M188 M53 M181 M146 M 568 M Dilution adjustment ————00 — Preferred dividends 0———2 M2 M — Diluted net income available to common stockholders 138 M139 M188 M53 M179 M144 M 564 M Basic earnings per share (Basic EPS) 2.812.974.041.254.193.62 13.1 Diluted earnings per share (Diluted EPS) 2.782.943.961.214.153.55 12.87 Average basic shares outstanding 49 M46.7 M46.5 M46.8 M42.8 M39.9 M — Diluted shares outstanding 49.6 M47.2 M47.5 M47.6 M43.2 M40.7 M — EBITDA 511 M501 M515 M430 M556 M514 M 2.02 B EBIT 490 M480 M496 M411 M537 M496 M 1.94 B Cost of revenue 296 M274 M299 M373 M303 M313 M 1.29 B Other cost of goods sold —————— — Depreciation & amortization (cash flow) 21 M21 M19 M19 M19 M18 M 75 M